This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Practicing Precision Medicine in Psoriatic Arthritis: Strategies and Digital Health Tools for Managing a Chronic Disease

Practicing Precision Medicine in Psoriatic Arthritis: Strategies and Digital Health Tools for Managing a Chronic Disease

Format

Webcast

Time to Complete

1.50 hours

Released

September 10, 2018

Expires

September 10, 2019
Add to Queue


Maximum Credits

1.50 / AMA PRA Category 1 CreditsTM
1.50 / ABIM MOC Points
1.50 / CNE Contact Hours (1.50 pharmacotherapeutic contact hours)
1.50 / CE for Pharmacists (0.15 CEUs)

An important note about ABIM MOC Part II points
Successful completion of this CME activity enables eligible participants to earn up to 1.50 ABIM-Part II Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. To claim MOC points, follow these easy steps:

Step 1: Complete all 3 questions under the "ABIM Part 2 Credit Questions" section, located at the bottom of the course evaluation form. This includes 1) attesting that our partner may submit your credits to ABIM, 2) attesting that you are ABIM board certified, 3) providing your ABIM #, and 4) providing your date of birth (MM/DD).

Step 2: Our partner, USF Health, will send your MOC points to your ABIM account within 1 month.

Accredited Provider

This educational initiative is co-provided by USF Health and CME Outfitters.

Commercial Supporter

This activity is supported by educational grants from Celgene Corporation; Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC.; and Novartis Pharmaceuticals Corporation.

Program Description

Psoriatic arthritis (PsA) is a serious and potentially disabling condition that affects approximately 30% of psoriasis patients. In addition to the physical and functional impairments from joint destruction, PsA also negatively impacts relationships, daily activities, work productivity, and overall quality of life. Several agents have been FDA-approved for the treatment of moderate-to-severe PsA since 2008, and there are still more currently under investigation. Digital health tools provide clinicians with multiple touchpoints and reminders; they can help reinforce SMART goals, provide tips, and link to additional resources. Despite the availability of effective PsA agents, clinicians are often not aware of new and pipeline agents for their patients with moderate-to-severe PsA. Often, clinicians are not implementing newer agents or digital health tools into clinical practice that lead to better patient outcomes.

In this CME Outfitters On Demand expert faculty will highlight the molecular targets of currently available and emerging biologic treatments for managing PsA, discuss individualized treatment plans, and provide updates on the latest clinical trials focused on the impact of long-term treatment, improving pain, and quality of life.

Intended Audience

Rheumatologists, dermatologists, physicians, physician assistants, nurse practitioners, nurses, and pharmacists who treat patients with psoriatic arthritis

Educational Objectives

At the end of this CME/CE activity, participants should be able to:

Physicians/PAs

  • Identify the molecular targets of currently available and emerging biologic treatments for the management of PsA
  • Develop individualized treatment plans for patients with PsA that weigh the risks and benefits of newer agents
  • Evaluate recent clinical trial data regarding the impact of long-term treatment on improving pain and quality of life

CNE/CPE

  • Identify the molecular targets of currently available and emerging biologic treatments for the management of PsA
  • Describe individualized treatment plans for patients with PsA that weigh the risks and benefits of newer agents
  • Evaluate recent clinical trial data regarding the impact of long-term treatment on improving pain and quality of life

Conflict Of Interest Disclosure Policy

It is the policy of USF Health and CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Faculty

Allan Gibofsky, MD, JD, MACR, FACP, FCLM (Moderator)
Professor of Medicine, Healthcare Policy and Research
Weill Medical College of Cornell University
Attending Rheumatologist
Hospital for Special Surgery
New York, NY

Dr. Gibofsky discloses the following:
Speakers Bureau: AbbVie Inc.; Celgene Corporation; Merck & Co., Inc.; and Pfizer, Inc.
Consultant: AbbVie Inc.; Celgene Corporation; Merck & Co., Inc; Pfizer Inc.; Samumed, LLC; and Sandoz.
Stock Shareholder: AbbVie Inc.; Bristol-Myers Squibb Company; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Pfizer Inc.

Joel M. Gelfand, MD, MSCE
Professor of Dermatology
Professor of Epidemiology
Vice Chair of Clinical Research and Medical Director, Dermatology Clinical Studies Unit
Director, Psoriasis and Phototherapy Treatment Center
University of Pennsylvania Perelman School of Medicine
Philadelphia, PA

Dr. Gelfand discloses the following:
Research Grants (to the Trustees of the University of Pennsylvania): AbbVie Inc.; Celgene Corporation; Janssen Biologics, Inc.; Novartis Corporation, Pfizer Inc.; Ortho Dermatologics, Inc.; and Sanofi.
Consultant: Bristol-Myers Squibb Company; Boehringer Ingelheim; GlaxoSmithKline; Janssen Biologics, Inc.; Novartis Corporation; Pfizer Inc.; Regeneron Pharmaceuticals, Inc.; Sanofi; and UCB Data and Safety Monitoring Board (DSMB).

Jennifer G. Kwan-Morley, MD
Rheumatologist
Premier Orthopaedics
Malvern, PA

Dr. Kwan-Morley has no disclosures to report.

Accredited Provider Disclosure

The CME Outfitters, LLC staff has nothing to disclose.
The USF Health staff has nothing to disclose.

Planners' and Managers' Disclosures

Jeffrey Helfand, DO, MS, (peer reviewer) has no disclosures to report.
Mae Ochoa, RPh, (peer reviewer) has no disclosures to report.
Kate Nelson, PHD, (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.

Credit

1.50

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

USF Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

USF Health designates this enduring material for a maximum of 1.50 AMA PRA Category 1 CreditsTM  . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Part II Points:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Credit

1.50

Type

CNE Contact Hour(s)

Accreditation Statement

CME Outfitters, LLC, is approved by the California Board of Registered Nursing.

Designation Statement

Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.50 contact hours.

Note to Nurse Practitioners and Clinical Nurse Specialists: the content of this activity pertains to pharmacology. Earn up to 1.50 contact hours of pharmacotherapeutic contact hours.

Credit

1.50

Type

CE for Pharmacists

Accreditation Statement

CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.50 contact hours (0.15 CEUs) Universal Activity Number:
0376-0000-18-018-H01-P

Type: Knowledge-based

Additional Credit Information

Note to Nurse Practitioners: Nurse practitioners can apply for AMA PRA Category 1 CreditTM   through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 CreditTM   from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

Note to Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM   from organizations accredited by the Accreditation Council for Continuing Medical Education.

Disclosure of Unlabeled Use

CME Outfitters, LLC, USF Health, and the faculty do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Instructions

There are no fees for participating in this CME/CE activity. To receive credit, participants must (1) read the learning objectives and disclosure statements, (2) study the educational activity, and (3) complete the post-test and activity evaluation form, including the certificate information section.

To obtain a certificate, participants must receive a score of 80% or better on the posttest. The post-test can be accessed at the end of the activity. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

If you have questions relating to the accreditation of this activity, please contact USF Health by email, cpdsupport@health.usf.edu, call 813.224.7860, or visit >www.cme.hsc.usf.edu.

USF is an Equal Opportunity/ Equal Access/ Affirmative Action Institution.

If you have any other questions relating to your certificate or other issues with this activity, please contact myCME.Support@haymarketmedical.com.

Privacy Policy

USF Health Office of Continuing Professional Development (OCPD) has created a privacy policy to demonstrate our commitment to guarding the privacy of our clients. The following statements disclose our practices on gathering and disseminating information for this web site.

The OCPD has security measures in place to protect the loss, misuse, and alteration of the information under our control. The OCPD does not share or sell any individual's contact information, financial information, or unique identifiers to any commercial supporter, advertiser, or third party without the specific permission of the individual.

If you have any questions about this privacy policy, please contact USF Health OCPD at cpdsupport@health.usf.edu.

CME Outfitters privacy policy

myCME privacy policy

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue